Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834

Q1 FY23 results · Apr–Jun 2022

Camlin Fine Sciences reported revenue from operations of ₹383.77 crore (up 16.0% from Q1 FY22) and net profit of ₹3.60 crore (down 84.9% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY23Q1 FY22YoYQ4 FY22QoQ
Revenue from operations383.77330.83+16.0%389.23−1.4%
Other income1.0310.55−90.3%21.32−95.2%
Total income384.80341.38+12.7%410.54−6.3%
Profit before tax14.5532.57−55.3%19.95−27.1%
Net profit for the period3.6023.78−84.9%13.33−73.0%
Attributable to shareholders of the company5.8922.36−73.7%15.13−61.1%
EPS, basic (₹)0.371.75not comparable1.16−68.1%
Net margin (%)0.97.23.4
Standalone · ₹ crore
ItemQ1 FY23Q1 FY22YoYQ4 FY22QoQ
Revenue from operations155.44145.73+6.7%201.39−22.8%
Other income12.743.83+232.4%7.56+68.5%
Total income168.17149.56+12.4%208.95−19.5%
Profit before tax5.166.97−26.0%22.06−76.6%
Net profit for the period5.274.73+11.5%15.75−66.5%
EPS, basic (₹)0.340.37not comparable1.21−71.9%
Net margin (%)3.43.27.8
Consolidated
Filed with BSE
13 Aug 2022, 12:18 IST
Board meeting
12 Aug 2022
Period
01 Apr 2022 to 30 Jun 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
13 Aug 2022, 12:18 IST
Board meeting
12 Aug 2022
Period
01 Apr 2022 to 30 Jun 2022
Review status
Unaudited
Source
XBRL filing on BSE